196 related articles for article (PubMed ID: 8186357)
1. An overview of the mechanism of action of antithrombin and its inherited deficiency states.
Blajchman MA
Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S5-11; discussion S59-64. PubMed ID: 8186357
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin-III-Hamilton, Ala 382 to Thr: an antithrombin-III variant that acts as a substrate but not an inhibitor of alpha-thrombin and factor Xa.
Austin RC; Rachubinski RA; Ofosu FA; Blajchman MA
Blood; 1991 May; 77(10):2185-9. PubMed ID: 2029579
[TBL] [Abstract][Full Text] [Related]
3. Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options.
Maclean PS; Tait RC
Drugs; 2007; 67(10):1429-40. PubMed ID: 17600391
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin-III-Hamilton: a gene with a point mutation (guanine to adenine) in codon 382 causing impaired serine protease reactivity.
Devraj-Kizuk R; Chui DH; Prochownik EV; Carter CJ; Ofosu FA; Blajchman MA
Blood; 1988 Nov; 72(5):1518-23. PubMed ID: 3179438
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin.
Ireland H; Lane DA; Thompson E; Walker ID; Blench I; Morris HR; Freyssinet JM; Grunebaum L; Olds R; Thein SL
Br J Haematol; 1991 Sep; 79(1):70-4. PubMed ID: 1911389
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin deficiency in three Japanese families: one novel and two reported point mutations in the antithrombin gene.
Maruyama K; Morishita E; Karato M; Kadono T; Sekiya A; Goto Y; Sato T; Nomoto H; Omi W; Tsuzura S; Imai H; Asakura H; Ohtake S; Nakao S
Thromb Res; 2013 Aug; 132(2):e118-23. PubMed ID: 23809926
[TBL] [Abstract][Full Text] [Related]
7. Inherited antithrombin deficiency: a review.
Patnaik MM; Moll S
Haemophilia; 2008 Nov; 14(6):1229-39. PubMed ID: 19141163
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin and its inherited deficiencies.
Perry DJ
Blood Rev; 1994 Mar; 8(1):37-55. PubMed ID: 8205009
[TBL] [Abstract][Full Text] [Related]
9. Thr90Ser Mutation in Antithrombin is Associated with Recurrent Thrombosis in a Heterozygous Carrier.
Lu Y; Villoutreix BO; Biswas I; Ding Q; Wang X; Rezaie AR
Thromb Haemost; 2020 Jul; 120(7):1045-1055. PubMed ID: 32422680
[TBL] [Abstract][Full Text] [Related]
10. Antithrombin and its inherited deficiency states.
van Boven HH; Lane DA
Semin Hematol; 1997 Jul; 34(3):188-204. PubMed ID: 9241705
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in understanding clotting and evaluating patients with recurrent thrombosis.
Alving BM; Comp PC
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1184-91. PubMed ID: 1415444
[TBL] [Abstract][Full Text] [Related]
12. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.
van Boven HH; Reitsma PH; Rosendaal FR; Bayston TA; Chowdhury V; Bauer KA; Scharrer I; Conard J; Lane DA
Thromb Haemost; 1996 Mar; 75(3):417-21. PubMed ID: 8701400
[TBL] [Abstract][Full Text] [Related]
13. Evidence linking familial thrombosis with a defective antithrombin III gene in two British kindreds.
Sacks SH; Old JM; Reeders ST; Weatherall DJ; Douglas AS; Winter JH; Rizza CR
J Med Genet; 1988 Jan; 25(1):20-4. PubMed ID: 3162535
[TBL] [Abstract][Full Text] [Related]
14. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
15. Revisiting antithrombin in health and disease, congenital deficiencies and genetic variants, and laboratory studies on α and β forms.
Amiral J; Seghatchian J
Transfus Apher Sci; 2018 Apr; 57(2):291-297. PubMed ID: 29784539
[TBL] [Abstract][Full Text] [Related]
16. Antithrombin heparin binding site deficiency: A challenging diagnosis of a not so benign thrombophilia.
Orlando C; Heylen O; Lissens W; Jochmans K
Thromb Res; 2015 Jun; 135(6):1179-85. PubMed ID: 25837307
[TBL] [Abstract][Full Text] [Related]
17. Antithrombin-Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis.
Jochmans K; Lissens W; Vervoort R; Peeters S; De Waele M; Liebaers I
Blood; 1994 Jan; 83(1):146-51. PubMed ID: 8274732
[TBL] [Abstract][Full Text] [Related]
18. Thrombosis in antithrombin-III-deficient persons. Report of a large kindred and literature review.
Demers C; Ginsberg JS; Hirsh J; Henderson P; Blajchman MA
Ann Intern Med; 1992 May; 116(9):754-61. PubMed ID: 1489375
[TBL] [Abstract][Full Text] [Related]
19. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
Rosenberg RD
Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency.
Alhenc-Gelas M; Plu-Bureau G; Hugon-Rodin J; Picard V; Horellou MH;
Thromb Haemost; 2017 Jun; 117(6):1040-1051. PubMed ID: 28300866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
